Sign in

CIK 0001723128

  • Large accelerated filer

Amneal Pharmaceuticals, Inc.

Sign in to watch
Ticker
AMRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
Phone
+1 908-947-3120
Former names
Atlas Holdings, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Conversion Director acquired 12,887,433 shares (conversion)
  3. 4 Open-market buy Director bought 50,000 shares at $2.39 ($119,500)
  4. 4 Open-market buy SVP, Chief Scientific Officer bought 30,000 shares at $2.41 ($72,300)
  5. 4 Open-market buy 10% owner bought 327,000 shares at $2.91 ($951,570)
  6. 4 Open-market buy Exec VP, Comm Optns bought 66,666 shares at $2.89 ($192,665)
  7. 4 Open-market buy 10% owner bought 1,642,300 shares at $3.04 ($4,992,592)
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market buy SVP, Chief Scientific Officer bought 7,000 shares at $8.48 ($59,360)
  12. 4 Open-market buy Exec VP, Comm Optns bought 19,000 shares at $9.46 ($179,740)
  13. 4 Open-market buy SVP, Specialty Commercial bought 15,000 shares at $9.88 ($148,200)
  14. 4 Shares withheld for taxes SVP, Specialty Commercial gave up 2,228 shares (to pay taxes)
  15. 4 Shares withheld for taxes Exec VP, Comm Optns gave up 8,353 shares (to pay taxes)
  16. 4 Shares withheld for taxes Executive Chairman gave up 12,529 shares (to pay taxes)
  17. 4 Shares withheld for taxes President and CEO gave up 21,609 shares (to pay taxes)
  18. 4 Shares withheld for taxes SVP, Chief HR Officer gave up 1,366 shares (to pay taxes)
  19. 4 Exercise or conversion Director acquired 6,107 shares (option exercise)
  20. 4 Exercise or conversion Director acquired 6,107 shares (option exercise)

Page 14 of 18 · 351 filings